Toho : Notice Regarding the Status of Acquisition of Company Stocks(124 KB)
March 03, 2024 at 09:10 pm EST
Share
Common stocks of the Company 2,500,000 shares (Maximum)
(3.87 % of the total number of outstanding shares (excluding treasury stock))
6 billion yen (Maximum)
from September 19, 2023 to March 31, 2024 Purchase at the Tokyo Stock Exchange
March 4, 2024
To whom it may concern:
Company Name:
TOHO HOLDINGS CO., LTD.
Corporate
Atsushi Udoh, Representative Director,
Representative:
CEO
(Prime Market of Tokyo Stock
Exchange Securities Code: 8129)
Contact:
Makoto Kawamura, Corporate Officer
and General Manager, Corporate
Strategy Division
(TEL: 81-3-6838-2803)
Notice Regarding the Status of Acquisition of Company Stocks
(Acquisition of Company Stocks Pursuant to Articles of Incorporation
under Article 165, Paragraph 2 of the Companies Act of Japan)
TOHO HOLDINGS CO., LTD. is pleased to announce the status of acquisition of its stocks pursuant to the provision of Article 156 of the Companies Act of Japan, as applied mutatis mutandis pursuant to Article 165, Paragraph 3 of the Companies Act of Japan. An outline of the acquisition in progress is as described below.
1.
Type of stock acquired:
Common stock of the Company
2.
Total number of shares acquired:
353,000 shares (on the contract basis)
3.
Total cost of stock acquired:
1,137,305,400 yen
4.
Period of acquisition:
from February 1, 2024 to February 29, 2024
5.
Method of acquisition:
Purchase at the Tokyo Stock Exchange
(Reference)
1.Details of resolution concerning acquisition of company stocks, which was resolved at the Board of Directors' meeting held on September 15, 2023.
(1) Type of stock acquired:
(2) Total number of shares acquired:
(3) Total cost of stock acquired:
(4) Period of acquisition:
(5) Method of acquisition:
2.Total number of company stocks acquired pursuant to the above resolution of the Board of Directors.
(as of February 29, 2024)
(1)
Total number of shares acquired:
1,740,600 shares (on the contract basis)
(2)
Total cost of stock acquired:
5,686,474,100 yen
Attachments
Original Link
Original Document
Permalink
Disclaimer
Toho Holdings Co. Ltd. published this content on
04 March 2024 and is solely responsible for the information contained therein. Distributed by
Public, unedited and unaltered, on
04 March 2024 02:10:07 UTC.
Toho Holdings Co Ltd is a Japan-based company mainly engaged in the pharmaceutical wholesale business. The Company operates through five business segments. The Pharmaceutical Wholesale segment purchases pharmaceuticals and medical-related products from pharmaceutical manufacturers and sells them to hospitals, clinics and dispensing pharmacies. It is also engaged in the provision of data processing system and rental of real estate. The Dispensing Pharmacy segment is engaged in the management of insurance dispensing pharmacies and dispensing pharmacies. The Pharmaceutical Manufacture and Sale segment is engaged in the manufacture and sale of generic drugs and contract manufacturing of injectable drugs. The Clinical Trial Facility Support segment is engaged in the provision of support for clinical trial facilities. The Information Equipment Sales segment is engaged in the planning and sale of information processing equipment.